Riccardo Mazzocchio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Riccardo Mazzocchio has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
A. Rossi
Sezione di Neurofisiologia Clinica, Dipartimento di Scienze Neurologiche, Neurochirurgiche e del Comportamento, Università di Siena, Siena, Italy
17 shared publicationsAlessandro Rossi
Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, Siena, Italy
12 shared publicationsA Rossi
8 shared publications- Traian Popa
MySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Lausanne, Switzerland
8 shared publications - Julie Duque
Cognition and Actions Lab, Institute of Neuroscience, UCLouvain, Brussels, Belgium
7 shared publications - Alessandro Rossi
University of Siena, Italy and Gianfranco Salvini Rehabilitative Research Foundation, Montevarchi, Italy
6 shared publications
Latest Publications
- 4 June 2018
- Published by Cambridge University Press (CUP)
- p. 111-114
Direct Central Nervous System Effects of Botulinum Neurotoxin
- 4 June 2018
- Published by Cambridge University Press (CUP)
- p. 111-114
Direct Central Nervous System Effects of Botulinum Neurotoxin
- 10 February 2017
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 40 (3) , 421-427
Impaired scaling of preparatory postural responses to repeated balance perturbations in Parkinsonian patients with comorbid white matter disease
BACKGROUND: Postural instability may result from altered sequencing of automatic motor programs for anticipatory postural corrections and/or impaired motor learning in Parkinson Disease (PD) patients. Comorbid white matter disease is a major determinant of axial motor impairment, leading to poorer stability than nigrostriatal dopaminergic denervation per se. OBJECTIVE: To assess differences in anticipatory control of postural stability function between subjects affected by PD with comorbid leukoaraiosis (LPD), idiopathic Parkinson disease (IPD) and elderly healthy subjects (EHS) as control group. METHODS: Eight patients with IPD, eight patients with LPD and eight age/weight matched elderly healthy subjects (EHS) were tested in standing position by measuring the Center of Pressure (CoP) along the anteroposterior axis (CoP-Y) while subjects were expecting three repeated backward surface translation. RESULTS: LPD patients positioned the CoP-Y significantly backward while waiting for the second and third platform translations, with respect to their COP-Y position in preparation for the first translation. The IPD and EHS showed no significant differences in the COP-Y position among the repeated perturbation trials. CONCLUSIONS: LPD patients show inability to rescale an effective preparatory postural pattern to known, repeated postural perturbations suggesting impaired sensory-motor strategies in anticipating perturbations. Anticipatory postural patterns remain effective in IPD patients.
- 10 February 2017
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 40 (3) , 421-427
Impaired scaling of preparatory postural responses to repeated balance perturbations in Parkinsonian patients with comorbid white matter disease
BACKGROUND: Postural instability may result from altered sequencing of automatic motor programs for anticipatory postural corrections and/or impaired motor learning in Parkinson Disease (PD) patients. Comorbid white matter disease is a major determinant of axial motor impairment, leading to poorer stability than nigrostriatal dopaminergic denervation per se. OBJECTIVE: To assess differences in anticipatory control of postural stability function between subjects affected by PD with comorbid leukoaraiosis (LPD), idiopathic Parkinson disease (IPD) and elderly healthy subjects (EHS) as control group. METHODS: Eight patients with IPD, eight patients with LPD and eight age/weight matched elderly healthy subjects (EHS) were tested in standing position by measuring the Center of Pressure (CoP) along the anteroposterior axis (CoP-Y) while subjects were expecting three repeated backward surface translation. RESULTS: LPD patients positioned the CoP-Y significantly backward while waiting for the second and third platform translations, with respect to their COP-Y position in preparation for the first translation. The IPD and EHS showed no significant differences in the COP-Y position among the repeated perturbation trials. CONCLUSIONS: LPD patients show inability to rescale an effective preparatory postural pattern to known, repeated postural perturbations suggesting impaired sensory-motor strategies in anticipating perturbations. Anticipatory postural patterns remain effective in IPD patients.
- 7 March 2016
- Published by Springer Nature in Experimental Brain Research
- Vol. 234 (7) , 1997-2005
Role of brain hemispheric dominance in anticipatory postural control strategies
Most of the cerebral functions are asymmetrically represented in the two hemispheres. Moreover, dexterity and coordination of the distal segment of the dominant limbs depend on cortico-motor lateralization. In this study, we investigated whether postural control may be also considered a lateralized hemispheric brain function. To this aim, 15 young subjects were tested in standing position by measuring center of pressure (COP) shifts along the anteroposterior axis (COP-Y) during dynamic posturography before and after continuous Theta Burst Stimulation (cTBS) intervention applied to the dominant or non-dominant M1 hand area as well as to the vertex. We show that when subjects were expecting a forward platform translation, the COP-Y was positioned significantly backward or forward after dominant or non-dominant M1 stimulation, respectively. We postulate that cTBS applied on M1 may have disrupted the functional connectivity between intra- and interhemispheric areas implicated in the anticipatory control of postural stability. This study suggests a functional asymmetry between the two homologous primary motor areas, with the dominant hemisphere playing a critical role in the selection of the appropriate postural control strategy.
- 7 March 2016
- Published by Springer Nature in Experimental Brain Research
- Vol. 234 (7) , 1997-2005
Role of brain hemispheric dominance in anticipatory postural control strategies
Most of the cerebral functions are asymmetrically represented in the two hemispheres. Moreover, dexterity and coordination of the distal segment of the dominant limbs depend on cortico-motor lateralization. In this study, we investigated whether postural control may be also considered a lateralized hemispheric brain function. To this aim, 15 young subjects were tested in standing position by measuring center of pressure (COP) shifts along the anteroposterior axis (COP-Y) during dynamic posturography before and after continuous Theta Burst Stimulation (cTBS) intervention applied to the dominant or non-dominant M1 hand area as well as to the vertex. We show that when subjects were expecting a forward platform translation, the COP-Y was positioned significantly backward or forward after dominant or non-dominant M1 stimulation, respectively. We postulate that cTBS applied on M1 may have disrupted the functional connectivity between intra- and interhemispheric areas implicated in the anticipatory control of postural stability. This study suggests a functional asymmetry between the two homologous primary motor areas, with the dominant hemisphere playing a critical role in the selection of the appropriate postural control strategy.
- 1 October 2014
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 114, 186-192
Differential effects of acute cortisol administration on deep and shallow episodic memory traces: A study on healthy males
- 1 October 2014
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 114, 186-192
Differential effects of acute cortisol administration on deep and shallow episodic memory traces: A study on healthy males
- Open Access
- 19 September 2014
- Published by Georg Thieme Verlag KG in Journal of Brachial Plexus and Peripheral Nerve Injury
- Vol. 5 (1) , e124-e130
Progesterone - new therapy in mild carpal tunnel syndrome? Study design of a randomized clinical trial for local therapy
Local corticosteroid injection for carpal tunnel syndrome (CTS) provides greater clinical improvement in symptoms one month after injection compared to placebo but significant symptom relief beyond one month has not been demonstrated and the relapse of symptoms is possible.
- 19 September 2014
- Published by Georg Thieme Verlag KG in Journal of Brachial Plexus and Peripheral Nerve Injury
- Vol. 5 (1) , e124-e130
Open AccessProgesterone - new therapy in mild carpal tunnel syndrome? Study design of a randomized clinical trial for local therapy
Local corticosteroid injection for carpal tunnel syndrome (CTS) provides greater clinical improvement in symptoms one month after injection compared to placebo but significant symptom relief beyond one month has not been demonstrated and the relapse of symptoms is possible.
- 26 February 2014
- Published by SAGE Publications in The Neuroscientist
- Vol. 21 (1) , 44-61
More than at the Neuromuscular Synapse
Botulinum neurotoxin type A (BoNT/A) is a metalloprotease that produces a sustained yet transitory blockade of transmitter release from peripheral nerve terminals. Local delivery of this neurotoxin is successfully employed in clinical practice to reduce muscle hyperactivity such as in spasticity and dystonia, and to relieve pain with long-lasting therapeutic effects. However, not all BoNT/A effects can be explained by an action at peripheral nerve terminals. Indeed, it appears that BoNT/A is endowed with trafficking properties similar to the parental tetanus neurotoxin and thus be able to directly affect the CNS. In this review, we present and discuss novel compelling evidence for a direct central effect of BoNT/A in both dorsal and ventral horns of the animal and human spinal cord after peripheral injection of the neurotoxin, with important consequences on pain and motor control. This new knowledge is expected to radically change the approach to the use of BoNT/A in the future. As BoNT/A central action appears to also contribute to functional improvement, for instance in human spastic gait, the challenge will be to develop new subtypes or BoNT derivatives with deliberate, cell-specific central effects in order to fully exploit the spectrum of BoNT/A therapeutic activity.
- 26 February 2014
- Published by SAGE Publications in The Neuroscientist
- Vol. 21 (1) , 44-61
More than at the Neuromuscular Synapse
Botulinum neurotoxin type A (BoNT/A) is a metalloprotease that produces a sustained yet transitory blockade of transmitter release from peripheral nerve terminals. Local delivery of this neurotoxin is successfully employed in clinical practice to reduce muscle hyperactivity such as in spasticity and dystonia, and to relieve pain with long-lasting therapeutic effects. However, not all BoNT/A effects can be explained by an action at peripheral nerve terminals. Indeed, it appears that BoNT/A is endowed with trafficking properties similar to the parental tetanus neurotoxin and thus be able to directly affect the CNS. In this review, we present and discuss novel compelling evidence for a direct central effect of BoNT/A in both dorsal and ventral horns of the animal and human spinal cord after peripheral injection of the neurotoxin, with important consequences on pain and motor control. This new knowledge is expected to radically change the approach to the use of BoNT/A in the future. As BoNT/A central action appears to also contribute to functional improvement, for instance in human spastic gait, the challenge will be to develop new subtypes or BoNT derivatives with deliberate, cell-specific central effects in order to fully exploit the spectrum of BoNT/A therapeutic activity.
- 18 February 2014
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 34 (1) , 185-192
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients
BACKGROUND: Botulinum neurotoxin A (BoNT-A) may reduce lower limb spasticity but its role in improving walking ability remains to be established. OBJECTIVE: To investigate the efficacy of simultaneous BoNT-A injections into several targeted spastic m
- 18 February 2014
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 34 (1) , 185-192
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients
BACKGROUND: Botulinum neurotoxin A (BoNT-A) may reduce lower limb spasticity but its role in improving walking ability remains to be established. OBJECTIVE: To investigate the efficacy of simultaneous BoNT-A injections into several targeted spastic m
- 28 October 2013
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 33 (2) , 217-223
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit
Background and purpose: There is a need for individuating those post-stroke patients who may benefit from an optimal and customised rehabilitation plan aiming at early reintegration in community life participation. This study investigated whether the gain of independence in complex Activities of Daily Living (ADL) may be predicted before the discharge from the stroke unit using simple bedside determinants. Methods: In 104 first-ever stroke patients with no previous disability, ten determinants at 10 days after stroke were selected. Multivariable logistic regression analysis was applied to identify the prognostic determinants able to predict independence in complex ADL, as measured by modified Rankin Scale grade ≤2. Results: The model shows that having a Barthel Index ≥9, a Motricity Index- Upper Limb ≥75, an age ≤70 and being a male resulted in 100% probability of achieving independence in complex ADL. If three of the four determinants were present, the probability was more than 90%. With the presence of two of the four determinants, the probability ranged from 87% to 28%. With the presence of only one determinant, the probability was 13%. Conclusions: Accurate prediction of independence in complex ADL can be made before the discharge from the stroke unit. The strength of the paretic upper limb, age, gender, and the ability of performing basic ADL are the significant variables. The probability of favorable prognosis depends on the presence and on the robustness of each single determinant.
- 28 October 2013
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 33 (2) , 217-223
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit
Background and purpose: There is a need for individuating those post-stroke patients who may benefit from an optimal and customised rehabilitation plan aiming at early reintegration in community life participation. This study investigated whether the gain of independence in complex Activities of Daily Living (ADL) may be predicted before the discharge from the stroke unit using simple bedside determinants. Methods: In 104 first-ever stroke patients with no previous disability, ten determinants at 10 days after stroke were selected. Multivariable logistic regression analysis was applied to identify the prognostic determinants able to predict independence in complex ADL, as measured by modified Rankin Scale grade ≤2. Results: The model shows that having a Barthel Index ≥9, a Motricity Index- Upper Limb ≥75, an age ≤70 and being a male resulted in 100% probability of achieving independence in complex ADL. If three of the four determinants were present, the probability was more than 90%. With the presence of two of the four determinants, the probability ranged from 87% to 28%. With the presence of only one determinant, the probability was 13%. Conclusions: Accurate prediction of independence in complex ADL can be made before the discharge from the stroke unit. The strength of the paretic upper limb, age, gender, and the ability of performing basic ADL are the significant variables. The probability of favorable prognosis depends on the presence and on the robustness of each single determinant.
- Open Access
- 2 November 2012
- Published by Wiley in The Journal of Physiology
- Vol. 591 (4) , 1017-1029
Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A
Key points: Botulinum neurototoxin type A (BoNT‐A) is known to block central synapses after muscular injection due to retrograde transport in animal models. BoNT‐A‐induced changes in the human CNS activity have been attributed so far to indirect mechanisms involving peripheral afferent inputs modified after muscular injection. The question of a possible direct central action of BoNT‐A in humans was further addressed by investigating the modification of spinal recurrent inhibition in stroke patients after BoNT‐A muscular injection. Recurrent inhibition from soleus motor axons to motoneurones supplying quadriceps was depressed after BoNT‐A injection in ankle plantarflexors. BoNT‐A, through retrograde transport, affects spinal synaptic transmission in humans. Abstract The natural target of the botulinum neurototoxin type A (BoNT‐A) is the neuromuscular junction. When injected into a muscle, BoNT‐A is internalized by motoneurone terminals where it functions as an endopeptidase, cleaving protein components of the synaptic machinery responsible for vesicle docking and exocytosis. As a result, BoNT‐A induces a characteristic flaccid paralysis of the affected muscle. In animal models, BoNT‐A applied in the periphery can also influence central activity via retrograde transport and transcytosis. An analogous direct central effect in humans is still debated. The present study was designed to address whether BoNT‐A modifies the activity of the spinal recurrent inhibitory pathways, when injected at muscular level, in humans. To avoid methodological bias, the recurrent inhibition from an injected muscle (soleus) was investigated on an untreated muscle (quadriceps), and stimulation parameters (producing recurrent inhibition) were monitored on a third non‐injected muscle but innervated by the same nerve as the soleus (flexor digitorum brevis). The experiments were performed on 14 post‐stroke patients exhibiting spasticity in ankle plantarflexors, candidates for BoNT‐A. One month after BoNT‐A, the level of recurrent inhibition was depressed. It is suggested that the depression of recurrent inhibition was induced by BoNT‐A, injected peripherally, through axonal transport and blockade of the cholinergic synapse between motoneurone recurrent collaterals and Renshaw cells.
- 2 November 2012
- Published by Wiley in The Journal of Physiology
- Vol. 591 (4) , 1017-1029
Open AccessBeyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A
Key points: Botulinum neurototoxin type A (BoNT‐A) is known to block central synapses after muscular injection due to retrograde transport in animal models. BoNT‐A‐induced changes in the human CNS activity have been attributed so far to indirect mechanisms involving peripheral afferent inputs modified after muscular injection. The question of a possible direct central action of BoNT‐A in humans was further addressed by investigating the modification of spinal recurrent inhibition in stroke patients after BoNT‐A muscular injection. Recurrent inhibition from soleus motor axons to motoneurones supplying quadriceps was depressed after BoNT‐A injection in ankle plantarflexors. BoNT‐A, through retrograde transport, affects spinal synaptic transmission in humans. Abstract The natural target of the botulinum neurototoxin type A (BoNT‐A) is the neuromuscular junction. When injected into a muscle, BoNT‐A is internalized by motoneurone terminals where it functions as an endopeptidase, cleaving protein components of the synaptic machinery responsible for vesicle docking and exocytosis. As a result, BoNT‐A induces a characteristic flaccid paralysis of the affected muscle. In animal models, BoNT‐A applied in the periphery can also influence central activity via retrograde transport and transcytosis. An analogous direct central effect in humans is still debated. The present study was designed to address whether BoNT‐A modifies the activity of the spinal recurrent inhibitory pathways, when injected at muscular level, in humans. To avoid methodological bias, the recurrent inhibition from an injected muscle (soleus) was investigated on an untreated muscle (quadriceps), and stimulation parameters (producing recurrent inhibition) were monitored on a third non‐injected muscle but innervated by the same nerve as the soleus (flexor digitorum brevis). The experiments were performed on 14 post‐stroke patients exhibiting spasticity in ankle plantarflexors, candidates for BoNT‐A. One month after BoNT‐A, the level of recurrent inhibition was depressed. It is suggested that the depression of recurrent inhibition was induced by BoNT‐A, injected peripherally, through axonal transport and blockade of the cholinergic synapse between motoneurone recurrent collaterals and Renshaw cells.
- 1 June 2012
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 30 (4) , 315-322
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke
The modified Rankin Scale (mRS) and the Barthel Index (BI) are the most common clinimetrical instruments for measuring disability after stroke. This study investigated the relationship between the BI and the mRS at multiple time points after stroke. The BI, which is a widely used instrument for longitudinal follow-up post-stroke, was used as reference to determine the effect of time on the sensitivity of the mRS in differentiating functional recovery. Ninety-two patients with first stroke and hemispheric brain lesion were evaluated using the BI and mRS at 10 days, 3 and 6 months. The Kruskal-Wallis test was applied to examine median differences in BI among the mRS levels at 10 days, 3 and 6 months with Dunn's correction for multigroup comparison. The Mann and Whitney test was used to compare median differences in BI scores between two aggregations of mRS grades (mRS=0-2, mRS=3-5) at the same time periods after stroke. BI score distribution amongst mRS grades overlapped at 10 days, differentiating only between extreme grades (no disability vs severe disability). At 3 months, independent patients with slight disability could be distinguished from dependent patients with marked disability. At 6 months, grade 2 and 3 overlapped no more, differentiating independence (class 0-2) from dependence (class 3-5). The largest transition to an independent functional status occurred from grade 4, at 3 months. Maximum sensitivity of mRS in differentiating functional recovery is reached at six months post-stroke.
- 1 June 2012
- Published by SAGE Publications in NeuroRehabilitation
- Vol. 30 (4) , 315-322
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke
The modified Rankin Scale (mRS) and the Barthel Index (BI) are the most common clinimetrical instruments for measuring disability after stroke. This study investigated the relationship between the BI and the mRS at multiple time points after stroke. The BI, which is a widely used instrument for longitudinal follow-up post-stroke, was used as reference to determine the effect of time on the sensitivity of the mRS in differentiating functional recovery. Ninety-two patients with first stroke and hemispheric brain lesion were evaluated using the BI and mRS at 10 days, 3 and 6 months. The Kruskal-Wallis test was applied to examine median differences in BI among the mRS levels at 10 days, 3 and 6 months with Dunn's correction for multigroup comparison. The Mann and Whitney test was used to compare median differences in BI scores between two aggregations of mRS grades (mRS=0-2, mRS=3-5) at the same time periods after stroke. BI score distribution amongst mRS grades overlapped at 10 days, differentiating only between extreme grades (no disability vs severe disability). At 3 months, independent patients with slight disability could be distinguished from dependent patients with marked disability. At 6 months, grade 2 and 3 overlapped no more, differentiating independence (class 0-2) from dependence (class 3-5). The largest transition to an independent functional status occurred from grade 4, at 3 months. Maximum sensitivity of mRS in differentiating functional recovery is reached at six months post-stroke.